Critical Care

Host: Peter Buch, MD, FACG, AGAF, FACP

Guest: Neena Abraham, MD, MS

Knowing how to manage anticoagulants and antithrombotics during acute GI bleeding is essential in preventing avoidable complications, including thromboembolism and delayed hemostasis. Dr. Peter Buch sits down with Dr. Neena Abraham to discuss the latest recommendations from major GI and cardiology societies and explore practical strategies for anticoagulant reversal, triage criteria, and endoscopic hemostasis. Dr. Abraham is a Professor of Medicine and the Medical Director of the Cardiogastroenterology Clinic at the Mayo Clinic in Phoenix.

Guest: Divya Shankar, MD

A recent study investigated whether pulse-dose corticosteroids offer a benefit over lower doses in managing acute exacerbations of idiopathic pulmonary fibrosis (IPF). Join Dr. Divya Shankar as she explains the real-world data, variability in prescribing patterns, and outcomes observed in different levels of care. Divya Shankar is an Assistant Professor of Medicine at Boston University Chobanian and Avedisian School of Medicine as well as a Pulmonary and Critical Care Physician at Boston Medical Center, and she spoke about this topic at the 2025 American Thoracic Society International Conference.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Phil Ayers, PharmD, BCNSP, FMSHP, FASHP

Though 100% soybean oil was once the standard for lipid emulsions in parenteral nutrition, mixed lipid emulsions have become more popular over the last decade. But there are a variety of patient-specific factors to consider before determining which type of lipid emulsion is appropriate. Dr. Charles Turck sits down with Dr. Phil Ayers to compare the available options and recommend strategies for selecting and monitoring patients. Dr. Ayers is a Clinical Associate Professor at the University of Mississippi School of Pharmacy and the Chief of Clinical Pharmacy Services in the Department of Pharmacy at Baptist Medical Center in Jackson.

Host: David Seiffge, MD

Host: Natalie Kreitzer, MD, MS

Host: W. Brian Gibler, MD, FACEP, FACC, FAHA

Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights into the latest treatment approaches, exploring recent data focused on reversing anticoagulation and the neurosurgical management of ICH. This program provides a comprehensive understanding of key strategies proven to be effective in these complex cases, highlighting the most up-to-date guideline-directed, evidence-based practices.

Host: Adrian R. Parry-Jones, FRCP, PhD

Host: W. Brian Gibler, MD, FACEP, FACC, FAHA

Host: Hiren C. Patel, PhD, FRCS

Host: David Seiffge, MD

Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights into the latest treatment approaches, exploring recent data focused on reversing anticoagulation and the neurosurgical management of ICH. This program provides a comprehensive understanding of key strategies proven to be effective in these complex cases, highlighting the most up-to-date guideline-directed, evidence-based practices.

Host: Hiren C. Patel, PhD, FRCS

Host: W. Brian Gibler, MD, FACEP, FACC, FAHA

Host: Adrian R. Parry-Jones, FRCP, PhD

Host: Thorsten Steiner, MD, PhD, MME

Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights into the latest treatment approaches, exploring recent data focused on reversing anticoagulation and the neurosurgical management of ICH. This program provides a comprehensive understanding of key strategies proven to be effective in these complex cases, highlighting the most up-to-date guideline-directed, evidence-based practices.

Host: W. Brian Gibler, MD, FACEP, FACC, FAHA

Host: Natalie Kreitzer, MD, MS

Host: Adrian R. Parry-Jones, FRCP, PhD

Host: Hiren C. Patel, PhD, FRCS

Host: David Seiffge, MD

Host: Thorsten Steiner, MD, PhD, MME

Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights into the latest treatment approaches, exploring recent data focused on reversing anticoagulation and the neurosurgical management of ICH. This program provides a comprehensive understanding of key strategies proven to be effective in these complex cases, highlighting the most up-to-date guideline-directed, evidence-based practices.

Host: Thorsten Steiner, MD, PhD, MME

Host: W. Brian Gibler, MD, FACEP, FACC, FAHA

Host: David Seiffge, MD

Host: Adrian R. Parry-Jones, FRCP, PhD

Host: Natalie Kreitzer, MD, MS

Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights into the latest treatment approaches, exploring recent data focused on reversing anticoagulation and the neurosurgical management of ICH. This program provides a comprehensive understanding of key strategies proven to be effective in these complex cases, highlighting the most up-to-date guideline-directed, evidence-based practices.

Host: Natalie Kreitzer, MD, MS

Host: W. Brian Gibler, MD, FACEP, FACC, FAHA

Host: Thorsten Steiner, MD, PhD, MME

Host: Adrian R. Parry-Jones, FRCP, PhD

Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights into the latest treatment approaches, exploring recent data focused on reversing anticoagulation and the neurosurgical management of ICH. This program provides a comprehensive understanding of key strategies proven to be effective in these complex cases, highlighting the most up-to-date guideline-directed, evidence-based practices.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Henry Rosenberg, MD

Malignant hyperthermia is an inherited disorder primarily recognized by anesthesia professionals. And since this condition can have significant consequences on a patient’s health, including their likelihood of surviving surgery, it’s important to know how to diagnose and treat malignant hyperthermia emergencies in operating room settings. Join Dr. Charles Turck as he dives deeper into this topic with Dr. Henry Rosenberg, a member of the Board of Directors of the Malignant Hyperthermia Association of the United States.